TNBC is a complex heterogenous and aggressive cancer form, whose cells do not express hormonal receptors and HER2, and, thus, the tumors are resistant to hormonal therapy and to the therapy blocking HER2 receptors [4]. This evidence concerns the gene NR4A1 and cancer.